Compound for treating oxidative stress in canines
AssigneeHemopet
InventorWinifred Jean Dodds
Life of this patent
Estimating the term…
Abstract
Managing and treating elevated OS biomarkers in mammals such as companion animals with at least one of the supplements alpha-lipoic acid, carnitine, co-enzyme Q-10, ginger, green tea, licorice, milk thistle, garlic, honey. resveratrol, soybeans, tomatoes, turmeric, vitamin D, vitamin E, or selenium. Other compounds are Zinc, Vitamin E, Vitamin C, Quercetin, L-glutamine and Robuvit. Diagnosing an oxidative stress (OS) in a mammal detects an OS biomarker, selectively isoprostane and other antioxidant biomarkers such as HODE, microRNAs, TAC, GSH, MDA, and TNF-alpha. The sample can be saliva.
Claims9
A method of treating a dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker comprising:
- a. mixing ingredients of a composition together to form a combination for ingestion by a dog,
- b. treating the dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker to achieve a treatment of the dog with the combination composition to reduce an isoprostane marker indicative of oxidative stress (OS) in the dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker, the composition being a combination of at least vitamin D, and selenium ingredients, to lower the level below 1.75 ng/ml, and
- c. reducing the isoprostane biomarker in the dog so treated by the composition combination after five to six months to a level below 1.75 ng/ml, wherein the isoprostane level is reduced by at least 40%, the reduction being determined by
- i. measuring the biomarker level in saliva from the dog with the previously diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker.
A method of treating a dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker comprising:
- a. mixing ingredients together in a combination for ingestion by a dog, and
- b. treating the dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker with the combination composition to reduce an isoprostane marker indicative of oxidative stress (OS) in the dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker, the composition being a combination consisting of vitamin D, selenium, alpha-lipoic acid, co-enzyme Q-10, green tea, and turmeric ingredients, to lower the level below 1.75 ng/ml in the dog with the previously diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker.
Dependencies are inferred from the claim text.